Certification Rate
98.8%
Very high DOL cert
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
Boston, MA NAICS: 54171
U.S. Department of Labor's OFLC discloses 579 Labor Condition Application filings naming Vertex Pharmaceuticals Incorporated from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 691 H-1B petitions naming Vertex Pharmaceuticals Incorporated through FY2024, and approved nearly every one of them: 98.7% approved (682 approvals, 9 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Vertex Pharmaceuticals Incorporated is listed in 579 DOL LCA filings, among the largest employer filers by filing volume in this extract. DOL certified 98.8% of those LCAs; the median listed offered wage is $133,485. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Boston, MA.
Vertex Pharmaceuticals Incorporated LCA outcome mix
579DOL LCA filings on record
Vertex Pharmaceuticals Incorporated vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
579 355th of 122824 higher than 122,469 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $66,300–$305,963 .
DOL LCA release change
Vertex Pharmaceuticals Incorporated has filed 579 LCAs (more volume than 100% of U.S. employer filers in this extract). DOL certification: 98.8%. Worksites span 6 states , led by MA.
Certification Rate
98.8%
Very high DOL cert
Avg. Salary
$133,485
Above portal avg
Total Workers
579
Large worker count
Vertex Pharmaceuticals Incorporated vs a peer vs the national average, from DOL LCA data.
132 completed-year filings in FY2023, 191 in FY2025. The scale spans up to twice the earlier year's count: the midpoint is unchanged and the endpoint is at least doubled.
Compensation range for H-1B positions at Vertex Pharmaceuticals Incorporated
H-1B LCA filing trends from FY2023 to FY2026
FY2026 is partial on this extract. Chart shows completed fiscal years only (through FY2025).
Most frequently listed job titles at Vertex Pharmaceuticals Incorporated
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Senior Statistical Programmer II | 26 | $131,085 |
| Senior Biostatistician II | 13 | $126,224 |
| Business Engagement & Technology Senior Principal Analyst | 12 | $163,731 |
| Business Engagement & Technology Principal Analyst | 12 | $153,636 |
| Analytical Development Senior Research Scientist | 12 | $125,358 |
| Principal Statistical Programmer | 10 | $142,030 |
| Business Engagement & Technology Principal Engineer | 10 | $159,899 |
| Analytical Development Research Scientist | 10 | $105,746 |
| Principal Biostatistician | 9 | $145,535 |
| Validation Engineering Senior Specialist | 8 | $112,326 |
| Health Economics & Outcomes Research Senior Manager | 8 | $143,473 |
| Process Dev Engineering Senior Scientist | 7 | $130,335 |
| Process Dev Engineering Scientist | 7 | $117,232 |
| Medicinal Chemistry Research Scientist | 7 | $113,945 |
| Director, Statistical Programming | 7 | $197,350 |
Where Vertex Pharmaceuticals Incorporated places H-1B workers across the United States
Cross-state DOL neighbors for Vertex Pharmaceuticals Incorporated - LCA filing-count and offered-wage axes, outside MA.
Nearest cross-state employer filers by LCA filing count (579 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($133,485 here).
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
ABS(total_petitions) peer at 576 LCAs (Δ 3 lighter vs Vertex Pharmaceuticals Incorporated); CERT-CLEAN · WAGE-PAR vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
ABS(total_petitions) peer at 576 LCAs (Δ 3 lighter vs Vertex Pharmaceuticals Incorporated); CERT-CLEAN · WAGE-BELOW vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
ABS(total_petitions) peer at 583 LCAs (Δ 4 heavier vs Vertex Pharmaceuticals Incorporated); CERT-SOLID · WAGE-PAR vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
ABS(total_petitions) peer at 575 LCAs (Δ 4 lighter vs Vertex Pharmaceuticals Incorporated); CERT-CLEAN · WAGE-PAR vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
MA pole at 3,809 LCAs stamps HEAVY-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Vertex Pharmaceuticals Incorporated's MID-BOOK.
Open the MA state board after the ABS peers. Vertex Pharmaceuticals Incorporated stamps MID-BOOK · CERT-CLEAN inside that worksite mix.
Vertex Pharmaceuticals Incorporated's WAGE-PREMIUM offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for Vertex Pharmaceuticals Incorporated to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.